EcoR1 Capital, LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 3:18 pm Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | EcoR1 Capital, LLC | 1,509,812 3.500% | -577,500 (-27.67%) | Filing |